TITLE:
Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft

CONDITION:
Peripheral Vascular Disease

INTERVENTION:
Remodulin (treprostinil sodium) Injection

SUMMARY:

      Approximately 30 patients will be enrolled in this 12-week study designed to assess the
      effect of continuous subcutaneous Remodulin therapy on the outcome of infrainguinal bypass
      grafts in patients with critical limb ischemia (CLI). Portions of the study will be
      conducted in the hospital and on an out-patient basis. The study will be conducted at
      multiple centers.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 85 Years
Criteria:

        -  Patients with critical limb ischemia and an appropriate reference lower-limb ischemic
             wound due to documented peripheral arterial disease who have had an autogenous vein
             infrainguinal bypass graft performed immediately prior to study initiation.
      
